McKenzie, Patti, Heather, Jeannine, Yvonne & Anne's Training Site
Dr. Timothy L. Vollmer


Program Director,
BNI Neuroimmunology Program

Barrow Neurological Institute
St. Joseph's Hospital and Medical Center
My Educational Video on MS and MS Trials
Produced by www.MDhealthChannel.com
This site is Private and is used only for training new Angel Editors, Bloggers & Columnists!
Visitors..Plus 221,000 on MySpace
Click here to go to our MySpace Page
HERE'S A FEW OF OUR 3,200 MySpace FRIENDS
CLICKING ON THE RED BUTTON BELOW
You'll get FREE Breaking News Alerts on new MS treatments as they are approved
PLUS: Plus...we will notify you when we produce videos like the one below that we filmed last year...with Dr. Timothy Vollmer to help you understand Tysabri's withdrawal from the market
Timothy L. Vollmer M.D.
Program Director, BNI Neuroimmunology Program
Barrow Neurological Institute
St. Joseph's Hospital and Medical Center


BARROW NEUROLOGICAL INSTITUTE'S
GRAND CANYON
RIM-RIM-HIKE


Organized by Dr. Robert F. Spetzler - Director, Barrow Neurological Institute

250 Photo-Slideshow


Click to view 1280 MS Walk photos!

"Join a trial at Barrow & receive all medication & study based procedures at no charge!"
Stan Swartz, CEO, The MD Health Channel

"WE PRODUCED THE FOLLOWING 9 VIDEOS FOR YOU!"
Simply click the "video" buttons below:

.

"MS Can Not
Rob You of Joy"
"I'm an M.D....my Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore

"OUR TEAM IS WORKING ON A CURE FOR MS"
Runtime: 54 sec
Runtime: 54 sec
Susan N. Rhodes
Multiple Sclerosis Research
Barrow Neurological Institute

"'The 2006 Barrow Neurological Institute at St. Joseph's Hospital MS "Walk on the Wild Side" raised more than $460,000 with 3,500 walkers! Click on the blue link above to view photos"

Chris Uithoven
President
National Multiple Sclerosis Society
Arizona Chapter


"THE MS SOCIETY OFFERS MANY PROGRAMS TO HELP...EVERYTHING FROM PILATES & SUPPORT GROUPS TO HORSEBACK RIDING"
Jerry Turner
Program Director
National Multiple Sclerosis Society
Arizona Chapter

Previious Posts

MS NEWS ARCHIVES: by week
January 2007  
November 2007  
April 2008  
July 2008  
December 2008  
January 2009  
February 2009  
March 2009  
March 2010  
April 2010  
May 2010  
August 2010  
May 2013  
June 2013  
July 2013  
January 2014  
February 2014  
March 2014  
April 2014  

This page is powered by Blogger. Isn't yours?

1/21/14

 
Masitinib, a new experimental drug to treat Multiple Sclerosis, is being tested in Europe

While there have been a number of success stories for MS research in 2013, last year saw yet another round of therapies aimed at treating Relapsing-Remitting Multiple Sclerosis rejected by the FDA, mainly on the grounds that the current experimental drugs for the disease feature too many side effects and not enough efficacy. In the case of secondary progressive multiple sclerosis, there were even fewer achievements in the realm of drug development. However, one novel drug for the treatment of Multiple Sclerosis continues to be tested in Europe, offering new hope for treating the disease, particularly in its most progressive forms. Masitinib, an experimental drug therapy developed by AB Science in France, is currently recruiting for its Phase 2b/3 testing phase, after presenting positive results from its previous clinical trial phase, which completed in 2011. The clinical trial puts Masitinib up against a placebo for the treatment of both Primary Progressive and Relapse-Free Secondary Progressive Multiple Sclerosis, in order to ascertain the drug’s safety in patients and efficacy in curtailing the progression of the disease. The program of the clinical trial is a rigorous 96-Week, Prospective, Multicenter, Randomized, Double-blind, Placebo-controlled study, featuring two Parallel-groups for a dose of Masitinib 6 mg/kg/Day versus the placebo.
READ MORE

Comments:

Post a Comment



<< Home